Skye Bioscience, Inc. (SKYE)
NASDAQ·Healthcare·Biotechnology
$0.71
-0.97%
Mkt Cap $37.23M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
Implied Upside
+1586.8%
Consensus $12.00 vs current $0.71
NASDAQ·Healthcare·Biotechnology
$0.71
-0.97%
Mkt Cap $37.23M
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
+1586.8%
Consensus $12.00 vs current $0.71